Literature DB >> 29523598

Effectiveness of antidepressants.

James McCormack1, Christina Korownyk2.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29523598     DOI: 10.1136/bmj.k1073

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

1.  Association between C-reactive protein and mood disorder in a representative sample of the Canadian population: analysis of CHMS data 2013-2014.

Authors:  Brenda M Y Leung; Chinenye Nwoke
Journal:  Can J Public Health       Date:  2020-03-04

2.  Fast-acting antidepressant-like effects of Reelin evaluated in the repeated-corticosterone chronic stress paradigm.

Authors:  Hector J Caruncho; Lisa E Kalynchuk; Kyle J Brymer; Jenessa Johnston; Justin J Botterill; Raquel Romay-Tallon; Milann A Mitchell; Josh Allen; Graziano Pinna
Journal:  Neuropsychopharmacology       Date:  2020-01-11       Impact factor: 7.853

3.  Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.

Authors:  Ellen Van Leeuwen; Mieke L van Driel; Mark A Horowitz; Tony Kendrick; Maria Donald; An Im De Sutter; Lindsay Robertson; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

Review 4.  Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis.

Authors:  Klaus Munkholm; Asger Sand Paludan-Müller; Kim Boesen
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

5.  Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines.

Authors:  Martin Plöderl; Michael P Hengartner
Journal:  BMC Psychiatry       Date:  2019-09-02       Impact factor: 3.630

6.  Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.

Authors:  Kiyomi Shinohara; Orestis Efthimiou; Edoardo G Ostinelli; Anneka Tomlinson; John R Geddes; Andrew A Nierenberg; Henricus G Ruhe; Toshi A Furukawa; Andrea Cipriani
Journal:  BMJ Open       Date:  2019-05-19       Impact factor: 2.692

7.  Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials.

Authors:  Michael P Hengartner; Janus C Jakobsen; Anders Sørensen; Martin Plöderl
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

Review 8.  How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding.

Authors:  Michael P Hengartner
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-08

9.  Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!

Authors:  Michael P Hengartner; Martin Plöderl
Journal:  Front Psychiatry       Date:  2018-10-17       Impact factor: 4.157

10.  Nature-Based Interventions and Mind-Body Interventions: Saving Public Health Costs Whilst Increasing Life Satisfaction and Happiness.

Authors:  Jules Pretty; Jo Barton
Journal:  Int J Environ Res Public Health       Date:  2020-10-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.